"Forrest General Hospital, located in Hattiesburg, Mississippi, is a leader in medical excellence in south Mississippi. The 547‐bed, Level II Regional Trauma Center and flagship hospital of Forrest Health, features specialty services in the following areas: behavioral health and addiction, cancer, emergency and trauma, heart and vascular, orthopedics and neurosurgery, general surgery, and women and children’s services. The hospital includes the general medical/surgical facility, Pine Grove Behavioral Health and Addiction Services, The Orthopedic Institute, Asbury Hospice House, Forrest General’s Cancer Center, Family Birthplace, Rehabilitation Center, Stroke Center, Women’s Surgery Center and Wound Healing Center."

During the past decade, Forrest General Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forrest General Hospital" #1 sponsor was "C. R. Bard" with 2 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "Anesiva, Inc." with 1 trials sponsored and "Atrium Medical Corporation" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forrest General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Uniformed Services University of the Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Forrest General Hospital" are "Bradycardia" (2 trials), "Breast Cancer" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "CIED Related Infection" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Forrest General Hospital" in a lesser frequency.

Most popular intervention types in "Forrest General Hospital" are "Drug" (8 trials), "Device" (6 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "AutoloGel" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forrest General Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Forrest General Hospital". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Forrest General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Forrest General Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".